ARTICLE
TITLE

Evaluation of drug information resources for interactions between therapeutic drugs and drugs of abuse

SUMMARY

Objective: The research evaluated point-of-care resources for scope, completeness, and consistency of information describing interactions between therapeutic drugs and drugs of abuse (DoA).Methods: A cross-sectional evaluation study was conducted focusing on seven resources: Clinical Pharmacology, Facts & Comparisons eAnswers, Lexicomp Online, Micromedex, Drug Interactions Analysis and Management, Drug Interaction Facts, and Stockley’s Drug Interactions. A sample of clinically relevant interactions was developed through review of tertiary literature and resources, and input was solicited from subject matter experts. Entries from each resource for each interaction were evaluated for scope (i.e., whether there was an entry for the interaction); completeness (i.e., whether there was information addressing mechanism; clinical effects, severity, course of action, and level of certainty, described as a median rating on a 5-point scale); and consistency (i.e., whether the information in the resource was similar to the majority) among resources with an entry.Results: Following review by subject matter experts, the final sample contained 159 interactions. Scope scores ranged from 0.6% (Drug Interactions Analysis and Management) to 43.4% (Lexicomp Online). Completeness scores ranged from 2 (interquartile range [IQR] 0 to 3, Stockley’s Drug Interactions) to 5 (IQR 5 to 5, Drug Interaction Facts, Micromedex, Facts & Comparisons eAnswers). Consistency scores ranged from 30.8% (Stockley’s Drug Interactions) to 87.1% (Clinical Pharmacology) for severity and from 15.4% (Facts & Comparisons eAnswers) to 71.4% (Drug Interaction Facts) for course of action.Conclusions: Although coverage of drug-DoA interactions was low and content was often inconsistent among resources, the provided information was generally complete.

 Articles related

Emiliana Tjitra,Suriadi Gunawan,Ferdinand Laihad,Harijani Marwoto,Sekartuti Sulaksono,Sumarjati Arjoso,Thomas L. Richie,Novianty ManurungEVALUATION OF ANTIMALARIAL DRUGS IN INDONESIA, 1981 - 1995    

Telah dilakukan evaluasi obat-obat antimalaria in-vitro dan in-vivo untuk menentukan pola resistensi dan memanfaatkan data ini untuk melakukan sistem pengamatan yang efektif. Semua penelitian pengobatan dan pencegahan malaria di lapangan dan rumah sakit ... see more


Mohammad Arifur Rahman, Laila Farzana    

Background: Expenditure on industry products (mostly drugs and devices) has spiraled over the last 15 years and accounts for substantial part of healthcare expenditure. The enormous financial interests involved in the development and marketing of drugs a... see more


Edith Frederika,Irine Normalina,Nasronudin Nasronudin,Rury Mega    

Antiretroviral drug discovery has encouraged a revolution in the care of people living with HIV, although it has not been able to cure diseases and to increase the challenge in terms of drug side effects. Side effects of antiretroviral drugs are fairly c... see more


Asmatanzeem Bepari, Nayana Sakre, Ishrat Rahman, Shaik Kalimulla Niazi, Asmabi M. Dervesh (Author)    

BACKGROUND: Cancer is a major burden and threat to global society. A wide range of chemotherapeutic agents is extensively used to treat cancer at different stages. Inappropriate drug use may also lead to the raised cost of medical care, adverse drug effe... see more


Gabrielle Racoski Custódio, Simona Renz Baldin, Jaqueline Franciele Caetano de Oliveira, Luciana Oliveira de Fariña    

Omega-3 is a polyunsaturated fat considered essential for the body. This compound is SOLD as a nutraceutical in Brazil, being widely consumed by the population due to its functional properties. According to its health benefits, this paper ... see more